by PVA_Admin | May 12, 2022 | 2022 Press Release, Press Release
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology TAKOMA PARK, Md.–(BUSINESS WIRE)–Jerome Canady Research Institute...
by PVA_Admin | May 5, 2022 | Cold Plasma Publications, Publications
The Granger Causal Effects of Canady Helios Cold Plasma on the Inhibition of Breast Cancer Cell Proliferation Annisa Elbedour, Xiaoqian Cheng, Saravana R. K. Murthy, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, and Jerome Canady Cold...
by PVA_Admin | Mar 15, 2022 | 2022 Press Release, Press Release
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), announced today that their recent...
by PVA_Admin | Mar 8, 2022 | Cold Plasma Publications, Publications
BCL2A1 regulates Canady Helios Cold Plasma-induced cell death in triple-negative breast cancer Saravana R. K. Murthy, Xiaoqian Cheng, Taisen Zhuang, Lawan Ly, Olivia Jones, Giacomo Basadonna, Michael Keidar, & Jerome Canady Breast cancer is the most common cause...
by PVA_Admin | Oct 6, 2021 | 2021 Press Release, Press Release
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological...
